Avita Medical, Inc. - Common Stock (NQ:RCEL)

13.41 +0.31 (+2.37%)

Delayed Quote Updated: 4:00 PM EDT, Oct 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Avita Medical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Why Ontrak Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 18, 2023

Gainers Ontrak, Inc. (NASDAQ: OTRK) shares jumped 101.7% to $1.1599 after the company announced new data that shows a reduction in depression and axiety symptoms for Ontrak Health's Wholehealth+...

Via Benzinga

Why Arcimoto Shares Are Trading Lower By 44%; Here Are 20 Stocks Moving Premarket ↗

January 18, 2023

Gainers Siyata Mobile Inc. (NASDAQ: SYTA) rose 41.5% to $0.3255 in pre-market trading after gaining 8% on Tuesday.

Via Benzinga

AVITA Medical: Q4 Earnings Insights ↗

August 11, 2022

AVITA Medical (NASDAQ:RCEL) reported its Q4 earnings results on Thursday, August 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Scheduled For August 11, 2022 ↗

August 11, 2022

Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

April 26, 2022

During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

January 18, 2023

We're starting the day with a breakdown of the biggest pre-market stock movers traders will want to watch on Wednesday morning!

Via InvestorPlace

Moderna, Tesla And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session ↗

January 18, 2023

U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

AVITA Medical Submits FDA PMA Application to Expand Indication to Vitiligo

December 19, 2022

From AVITA Medical

Via GlobeNewswire

AVITA Medical Announces Results of 2022 Annual Meeting of Stockholders

December 12, 2022

From AVITA Medical

Via GlobeNewswire

AVITA Medical Submits FDA PMA Supplement to Further Expand Indication to Soft Tissue Repair

December 12, 2022

From AVITA Medical

Via GlobeNewswire

AVITA Medical® to Present at the Piper Sandler 34th Annual Healthcare Conference

November 21, 2022

From AVITA Medical

Via GlobeNewswire

AVITA Medical® to Host Investor Webinar Briefing

November 16, 2022

From AVITA Medical

Via GlobeNewswire

AVITA Medical Reports Third Quarter 2022 Financial Results

November 10, 2022

From AVITA Medical

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 10, 2022

Gainers NexImmune (NASDAQ:NEXI) shares rose 38.8% to $0.7 during Thursday's pre-market session. The market value of their outstanding shares is at $16.9 million.

Via Benzinga

AVITA Medical Announces Achievement of Co-Primary Endpoints in Updated Analysis of Pivotal Trial of RECELL® System for Soft Tissue Repair

November 09, 2022

From AVITA Medical

Via GlobeNewswire

Earnings Scheduled For November 10, 2022 ↗

November 10, 2022

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings for its third quarter.

Via Benzinga

AVITA Medical Announces FDA Breakthrough Device Designations for the RECELL® System

November 03, 2022

From AVITA Medical

Via GlobeNewswire

AVITA Medical to Announce Third Quarter 2022 Financial Results

October 20, 2022

From AVITA Medical

Via GlobeNewswire

AVITA Medical Appoints Industry Leader James Corbett as Chief Executive Officer

September 28, 2022

From AVITA Medical

Via GlobeNewswire

Investor Webinar Briefing (RCEL, AVH)

September 19, 2022

Valencia, California and Melbourne, Australia--(Newsfile Corp. - September 19, 2022) - AVITA Medical, Inc. (NASDAQ: RCEL) (ASX: AVH), a regenerative...

Via Newsfile

Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary ↗

September 12, 2022

Via Benzinga

AVITA Shares Climb Following Positive Results From RECELL System Study In Stable Vitiligo Lesions ↗

September 12, 2022

AVITA Medical (NASDAQ: RCEL) reveals positive top-line results from a pivotal trial evaluating the safety and effectiveness of the RECELL System for repigmentation of stable vitiligo lesions.

Via Benzinga

Recap Of Thursday's Biotech Catalysts - End Of the Day Summary ↗

August 11, 2022

Via Benzinga

AVITA Medical Shares Climb On Topline Results From Soft Tissue Reconstruction Study, Sees PMA Submission By Year-end ↗

August 11, 2022

AVITA Medical (NASDAQ: RCEL) announced topline results from its pivotal trial evaluating the safety and effectiveness of the RECELL System combined with meshed autograft for reduction of donor skin...

Via Benzinga

AVITA Medical: Q3 Earnings Insights ↗

May 12, 2022

AVITA Medical (NASDAQ:RCEL) reported its Q3 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings AVITA Medical beat estimated...

Via Benzinga

Earnings Scheduled For May 12, 2022 ↗

May 12, 2022

Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter.

Via Benzinga

AVITA Medical Modifies BARDA Contract For RECELL System In Soft Tissue Reconstruction ↗

March 22, 2022

Biomedical Advanced Research and Development Authority (BARDA) has

Via Benzinga

AVITA Medical Inks Supply Pact With Premier For RECELL System ↗

March 03, 2022

AVITA Medical Inc (NASDAQ: RCEL) has been awarded a group purchasing agreement with Premier Inc (NASDAQ: PINC) The new agreement allows Premier members,...

Via Benzinga

The Daily Biotech Pulse: NuCana Shelves Biliary Tract Cancer Study, Tricida Data Readout Pushed Back Due to Ukrainian Crisis, Synlogic Names New CFO ↗

March 03, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus NuCana Discontinues Biliary Tract Cancer Study Following Futility Analysis...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

March 15, 2022

During Tuesday's session, 454 stocks hit new 52-week lows. Intriguing Points From Today's 52-Week Lows: Taiwan Semiconductor (NYSE:TSM) was the largest company by...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.